A Quote, Financials, Valuation and Earnings

Azenta has a net margin of 18.92% compared to Agilent Technologies's net margin of -9.04%. Agilent Technologies's return on equity of 20.82% beat Azenta's return on equity of -7.97%.

Agilent Technologies has a consensus price target of $151.56, signalling upside risk potential of 29.55%. On the other hand Azenta has an analysts' consensus of $58.67 which suggests that it could grow by 59.74%. Given that Azenta has higher upside potential than Agilent Technologies, analysts believe Azenta is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.108, which suggesting that the stock is 10.779% more volatile than S&P 500. In comparison Azenta has a beta of 1.521, suggesting its more volatile than the S&P 500 by 52.14%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.82%. Azenta offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Azenta pays out -- of its earnings as a dividend. Agilent Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Azenta quarterly revenues of $147.5M. Agilent Technologies's net income of $318M is higher than Azenta's net income of -$13.3M. Notably, Agilent Technologies's price-to-earnings ratio is 26.97x while Azenta's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 5.19x versus 2.84x for Azenta. Usually stocks with elevated PS ratios are considered overvalued.

Bio-Rad Laboratories has a net margin of 18.92% compared to Agilent Technologies's net margin of -107.24%. Agilent Technologies's return on equity of 20.82% beat Bio-Rad Laboratories's return on equity of -23.87%.

Agilent Technologies has a consensus price target of $151.56, signalling upside risk potential of 29.55%. On the other hand Bio-Rad Laboratories has an analysts' consensus of $372.83 which suggests that it could grow by 52.17%. Given that Bio-Rad Laboratories has higher upside potential than Agilent Technologies, analysts believe Bio-Rad Laboratories is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.108, which suggesting that the stock is 10.779% more volatile than S&P 500. In comparison Bio-Rad Laboratories has a beta of 0.984, suggesting its less volatile than the S&P 500 by 1.622%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.82%. Bio-Rad Laboratories offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Bio-Rad Laboratories pays out -- of its earnings as a dividend. Agilent Technologies's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Bio-Rad Laboratories quarterly revenues of $667.5M. Agilent Technologies's net income of $318M is higher than Bio-Rad Laboratories's net income of -$715.8M. Notably, Agilent Technologies's price-to-earnings ratio is 26.97x while Bio-Rad Laboratories's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 5.19x versus 2.69x for Bio-Rad Laboratories. Usually stocks with elevated PS ratios are considered overvalued.

Bruker has a net margin of 18.92% compared to Agilent Technologies's net margin of 1.4%. Agilent Technologies's return on equity of 20.82% beat Bruker's return on equity of 6.78%.

Agilent Technologies has a consensus price target of $151.56, signalling upside risk potential of 29.55%. On the other hand Bruker has an analysts' consensus of $68.42 which suggests that it could grow by 52.14%. Given that Bruker has higher upside potential than Agilent Technologies, analysts believe Bruker is more attractive than Agilent Technologies.

Agilent Technologies has a beta of 1.108, which suggesting that the stock is 10.779% more volatile than S&P 500. In comparison Bruker has a beta of 1.184, suggesting its more volatile than the S&P 500 by 18.406%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.82%. Bruker offers a yield of 0.45% to investors and pays a quarterly dividend of $0.05 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Bruker pays out 26.7% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Bruker quarterly revenues of $979.6M. Agilent Technologies's net income of $318M is higher than Bruker's net income of $13.7M. Notably, Agilent Technologies's price-to-earnings ratio is 26.97x while Bruker's PE ratio is 59.17x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 5.19x versus 2.00x for Bruker. Usually stocks with elevated PS ratios are considered overvalued.

Revvity has a net margin of 18.92% compared to Agilent Technologies's net margin of 12.98%. Agilent Technologies's return on equity of 20.82% beat Revvity's return on equity of 3.45%.

Agilent Technologies has a consensus price target of $151.56, signalling upside risk potential of 29.55%. On the other hand Revvity has an analysts' consensus of $141.19 which suggests that it could grow by 27.98%. Given that Agilent Technologies has higher upside potential than Revvity, analysts believe Agilent Technologies is more attractive than Revvity.

Agilent Technologies has a beta of 1.108, which suggesting that the stock is 10.779% more volatile than S&P 500. In comparison Revvity has a beta of 1.064, suggesting its more volatile than the S&P 500 by 6.441%.

Agilent Technologies has a quarterly dividend of $0.25 per share corresponding to a yield of 0.82%. Revvity offers a yield of 0.25% to investors and pays a quarterly dividend of $0.07 per share. Agilent Technologies pays 21.26% of its earnings as a dividend. Revvity pays out 12.74% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Agilent Technologies quarterly revenues are $1.7B, which are larger than Revvity quarterly revenues of $729.4M. Agilent Technologies's net income of $318M is higher than Revvity's net income of $94.6M. Notably, Agilent Technologies's price-to-earnings ratio is 26.97x while Revvity's PE ratio is 49.92x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Agilent Technologies is 5.19x versus 4.92x for Revvity. Usually stocks with elevated PS ratios are considered overvalued.